Fresh from his recent research of Belgium’s legal market, Ashish Sareen highlights the Benelux nation’s ongoing contribution to halting the spread of Covid-19
If you were asked what Belgium is best known for, you would probably answer with Hergé’s Tintin, football, chocolates, waffles, frites, the creation of the saxophone, and world-beating craft beer brewed by Trappist monks. It is unlikely, however, that you would mention biotech in the same breath as the above. With most of its activity in …
Continue reading “Tintin, beer, and biotech?”
Exchange Chambers’ John Jones QC and Ian Whitehurst, along with CCL Group’s Adam Irwin, consider private prosecutions in a digital age
Corporate crime in the United Kingdom takes many forms and the increasing dominance of the digital economy has only sought to heighten the problem. Sadly, this is happening against a backdrop of increasing neglect by law enforcement, owing to insufficient economic resources; a lack of suitably qualified individuals with the appropriate skills; and an apparent …
Continue reading “Taking care of business”
As vice president in charge of portfolio planning and IP litigation at Sun Pharmaceuticals, India’s largest pharma company and the largest Indian pharma company operating in the US, Bharati Nadkarni has been behind some of the biggest pharma cases in recent times. fivehundred catches up with her about developments facing lawyers in the pharma sector
Bharati, please can you explain the challenges you face in bringing litigation in the pharma space? The approach to litigation in the pharmaceuticals sector is a little different from the approach taken in other industries. There are two main reasons for this. First, patents are territorial. A patent approved in the US may not get …
Continue reading “Pain and gain in pharma litigation”
Dr Dana Ferchland talks to Louis W. Beardell, Jr, Dion Bregman, and Eric Kraeutler about Morgan Lewis Bockius’ growing patent practice, recent market trends, and the rise of ‘big data’ to drive patenting strategies and transactions
Your patent practice has grown significantly over the past few years, especially in 2018. How has this bolstered patent practice added to the firm’s existing strengths? Louis W. Beardell, Jr., deputy practice leader: Recent additions to Morgan Lewis’s patent practice in Chicago, Orange County, San Francisco, and Washington, DC have boosted our ability to offer …
Continue reading “The business of patents”
Serious thought should be given to what BRI arbitrations really look like beyond the popular headlines, says Swee Im TAN, international arbitrator and member of 39 Essex Chambers
Asia and the Belt and Road Initiative (BRI) feature large in the arbitration scene, especially in the construction and energy fields where infrastructure projects capture headlines on a regular basis. However, one pauses to consider what the BRI is really all about. The popular view of the BRI is large infrastructure projects funded by the …
Continue reading “Arbitration and Asia – opportunities and challenges”
Practice management
With consistent tier 1 placement within The Legal 500 rankings, US editor (content), Helen Donegan takes a closer look at Kirkland & Ellis’ New York litigation team to find out what they attribute to this success, and what factors are involved in building a top tier litigation practice
Kirkland & Ellis benefits from a well-resourced and expert New York litigation team comprised of over 80 lawyers – including 25 partners and over 50 associates. These individuals are a key team within the overall figure of 700 Kirkland & Ellis litigators worldwide, and were described within The Legal 500’s 2019 US guide as being …
Continue reading “Building and sustaining a top tier litigation practice”
